RS686548 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Sphingomyelin (d18:1/19:0, d19:1/18:0) levels | T | OR: 0.22 | 2E-29 | PubMed |
| Monohexosylceramide (d16:1/24:0) levels | T | OR: 0.24 | 1E-26 | PubMed |
| Sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0) levels | T | OR: 0.19 | 4E-24 | PubMed |
| Sphingomyelin (d18:1/20:0, d16:1/22:0) levels | T | OR: 0.19 | 1E-23 | PubMed |
| Alanine aminotransferase levels | A | β: 0.015 | 2E-22 | PubMed |
| Triglyceride percentage of total lipids in intermediate-density lipoprotein | A | β: 0.029 | 9E-21 | PubMed |
| Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels | T | OR: 0.17 | 7E-19 | PubMed |
| Low-density lipoprotein levels | A | β: 0.015 | 8E-19 | PubMed |
| Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels | T | OR: 0.12 | 7E-17 | PubMed |
| Serum metabolite ratios in chronic kidney disease | T | OR: 0.33 | 5E-16 | PubMed |
| Plasma sphingomyelin (d18:0/18:0, d19:0/17:0)* levels in chronic kidney disease | T | OR: 0.11 | 8E-16 | PubMed |
| Ceramide (d18:1/26:0) levels | T | OR: 0.18 | 1E-15 | PubMed |
| Alanine aminotransferase levels | A | OR: 7.62 | 2E-14 | PubMed |
| Gallstone disease | T | OR: 0.94 | 4E-14 | PubMed |
| Sphingomyelin (d18:2/21:0, d16:2/23:0) levels | T | OR: 0.14 | 6E-14 | PubMed |
| Ceramide (d18:2/24:1, d18:1/24:2) levels | T | OR: 0.18 | 3E-13 | PubMed |
| Plasma N-stearoyl-sphingosine (d18:1/18:0)* levels in chronic kidney disease | T | β: 0.08 | 1E-12 | PubMed |
| Sphingomyelin(41:2)_[M+H]1+ levels | G | OR: 0.11 | 2E-10 | PubMed |
| Phosphatidylcholine-O(36:1)_[M+H]1+/Phosphatidylethanolamine-O(39:1)_[M+H]1+/Phosphatidylcholine-P(36:0)_[M+H]1+ levels | T | β: 0.068 | 2E-10 | PubMed |
| Sphingomyelin(39:1)_[M+H]1+ levels | A | β: 0.053 | 2E-10 | PubMed |